chr19-45765548-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_175875.5(SIX5):c.2173C>T(p.Leu725=) variant causes a synonymous change. The variant allele was found at a frequency of 0.000312 in 1,613,474 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00017 ( 2 hom. )
Consequence
SIX5
NM_175875.5 synonymous
NM_175875.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.00
Genes affected
SIX5 (HGNC:10891): (SIX homeobox 5) The protein encoded by this gene is a homeodomain-containing transcription factor that appears to function in the regulation of organogenesis. This gene is located downstream of the dystrophia myotonica-protein kinase gene. Mutations in this gene are a cause of branchiootorenal syndrome type 2. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 19-45765548-G-A is Benign according to our data. Variant chr19-45765548-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 512355.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 253 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SIX5 | NM_175875.5 | c.2173C>T | p.Leu725= | synonymous_variant | 3/3 | ENST00000317578.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SIX5 | ENST00000317578.7 | c.2173C>T | p.Leu725= | synonymous_variant | 3/3 | 1 | NM_175875.5 | P1 | |
ENST00000559756.1 | n.764G>A | non_coding_transcript_exon_variant | 1/2 | 3 | |||||
SIX5 | ENST00000560160.1 | c.*383C>T | 3_prime_UTR_variant | 2/2 | 2 | ||||
SIX5 | ENST00000560168.1 | c.*1599C>T | 3_prime_UTR_variant | 3/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.00162 AC: 247AN: 152226Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
247
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000390 AC: 98AN: 251196Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135878
GnomAD3 exomes
AF:
AC:
98
AN:
251196
Hom.:
AF XY:
AC XY:
42
AN XY:
135878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000171 AC: 250AN: 1461130Hom.: 2 Cov.: 29 AF XY: 0.000161 AC XY: 117AN XY: 726900
GnomAD4 exome
AF:
AC:
250
AN:
1461130
Hom.:
Cov.:
29
AF XY:
AC XY:
117
AN XY:
726900
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00166 AC: 253AN: 152344Hom.: 0 Cov.: 33 AF XY: 0.00179 AC XY: 133AN XY: 74484
GnomAD4 genome
AF:
AC:
253
AN:
152344
Hom.:
Cov.:
33
AF XY:
AC XY:
133
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 15, 2020 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 15, 2022 | - - |
Branchiootorenal syndrome 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 06, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at